SCHEMBL3296373

SCHEMBL3296373

CCOC(=O)c1cn(N(C)C(=O)OC(C)(C)C)c2ccc(CCCNC(=O)OC(C)(C)C)cc2c1=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.39
MAPT P10636 2/20 0.36
KDM4E B2RXH2 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
ADRB2 P07550 1/20 0.36
KMT2A Q03164 2/20 0.35
GABRA1 P14867 1/20 0.35
GABRB2 P47870 1/20 0.35
P2RX3 P56373 1/20 0.34
TBK1 Q9UHD2 1/20 0.34
BRD4 O60885 1/20 0.34
ADORA3 P0DMS8 1/20 0.34
ADORA2A P29274 1/20 0.34
PTGER4 P35408 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34
MEN1 O00255 1/20 0.33
THRB P10828 1/20 0.33
HPGD P15428 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3292992 0.90 P2RY14 (0.38) LMNAKDM4EKMT2ABRD4PTGER4
SCHEMBL4169502 0.86 LMNA (0.42) LMNAMAPTKDM4ENPSR1KMT2A
SCHEMBL3982430 0.85 LMNA (0.56) LMNAMAPTKDM4EKMT2AP2RX3
SCHEMBL3288787 0.85 DDB1 (0.41) LMNAMAPTKDM4ENPSR1ADRB2
SCHEMBL4169399 0.84 LMNA (0.41) LMNAMAPTKDM4ENPSR1ADRB2
SCHEMBL5255090 0.83 LMNA (0.46) LMNAMAPTKDM4ENPSR1KMT2A
SCHEMBL4176943 0.83 KMT2A (0.44) LMNAMAPTKDM4ENPSR1ADRB2
SCHEMBL4173128 0.82 LMNA (0.48) LMNAMAPTKDM4ENPSR1KMT2A
SCHEMBL5434373 0.82 ADRB2 (0.46) LMNAMAPTKDM4ENPSR1ADRB2
SCHEMBL5437011 0.82 LMNA (0.45) LMNAMAPTKDM4ENPSR1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7718621-B2 Macrolones—amino substituted quinolones GLAXO GROUP LTD. (GB) 2010-05-18 US disclosed
US-20080090773-A1 Macrolones - Amino Substituted Quinolones GLAXO GROUP LIMITED (GB) 2008-04-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080090773-A1 Macrolones - Amino Substituted Quinolones MRPL21, Q6ZSR9, QARS1 LMNA 1318/4885MAPT 3434/4885KDM4E 2889/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.